Actas Dermo-Sifiliográficas, 2022 Background: Cutaneous manifestations are complicated to treat in rare diseases. The main aim of this study was to analyze the impact of compounded drugs prepared by hospital pharmacists on the quality of life of patients with genodermatoses. Material and
M. Oro-Ayude +4 more
doaj +1 more source
Clinical experience with orphan drugs for rare metabolic diseases
Anales de Pediatría (English Edition), 2022 Introduction: Inborn errors of metabolism are a highly heterogeneous group of orphan diseases. Diet therapy and enzyme and coenzyme replacement are the most frequently used treatment.
Alicia Caso-González +6 more
doaj +1 more source
Desafíos en el empleo de los medicamentos huérfanos
Humanidades Médicas, 2023 Las enfermedades raras son aquellas que tienen baja prevalencia y que, por lo tanto, el desarrollo de medicamentos para tratarlas no es rentable para las empresas farmacéuticas debido a la baja demanda.
Ivo Heyerdahl-Viau
doaj
[Technological and productive trajectory of the human vaccine industry in Mexico: post-Covid-19 perspectives]. [PDF]
Rev Salud Publica (Bogota), 2023 Pérez-Hernández MDPM +1 more
europepmc +1 more source
Reflections on the performance of the Colombian Minister of Health regarding the management of the COVID-19 pandemic, sexual and reproductive health and public health [PDF]
Rev Colomb Obstet Ginecol, 2022 Tolosa-Ardila JE.
europepmc +1 more source
[Interest in disinterestedness in the epidemiology of health systems and services]. [PDF]
Salud Colect, 2023 Spinelli H.
europepmc +1 more source
[Potential use of liposomes in tuberculosis treatment]. [PDF]
Rev Med Inst Mex Seguro Soc, 2023 Jacobo-Delgado YM +2 more
europepmc +1 more source
[Intrahepatic Cholestasis and Hyperbilirubinemia Induced by Hyperthyroi- dism: A Case Series]. [PDF]
Acta Gastroenterol Latinoam, 2023 Garcés JPS +5 more
europepmc +1 more source
COVID-19 from a cardiovascular perspective [PDF]
Arch Cardiol Mex, 2021 Bryce-Moncloa A +5 more
europepmc +1 more source
The right to legal, safe and free abortion in Argentina: obstacles and challenges to the policy in force, 18 months after its implementation (2021-2022). [PDF]
Salud Colect, 2023 Anzorena CC.
europepmc +1 more source